Hillstar Bio is focused on developing precision immunotherapies aimed at transforming the treatment landscape for autoimmune diseases. Their innovative approach involves selectively depleting pathogenic cells that contribute to these conditions while preserving healthy immune cells. This targeted strategy is designed to provide patients with long-lasting relief and facilitate an immune reset, potentially improving their overall health and quality of life.

The company is advancing a pipeline of products that leverage this precision immunotherapy technology. By honing in on the specific cells responsible for autoimmune responses, Hillstar Bio aims to create therapies that not only alleviate symptoms but also address the underlying causes of these diseases. This approach represents a significant shift in how autoimmune conditions may be treated in the future, emphasizing the importance of precision and personalization in medical interventions.

United States

Hillstar Bio is a precision immunology company based in Boston's Seaport neighborhood advancing a portfolio of programs against autoimmune diseases with unmet or underserved medical needs.

Hillstar Bio

Company Details